Latest News and Press Releases
Want to stay updated on the latest news?
-
TORONTO, April 06, 2026 (GLOBE NEWSWIRE) -- McChip Resources Inc. (the “Company”) (TSX-V:MCS-X) today announced that the Board of Directors of the Company (the “Board”) has declared a special...
-
NEW YORK and WALTHAM, Mass., April 06, 2026 (GLOBE NEWSWIRE) -- Dianthus Therapeutics, Inc. (Nasdaq: DNTH), a clinical-stage biotechnology company dedicated to developing next-generation therapies...
-
DMG Blockchain Solutions Receives 2 MW of SCIF-Rated Prefabricated Data Center
-
Friedland Enterprises Files Amended Schedule 13D on Lulu's Fashion Lounge Holdings (LVLU), Publishes Independent FY2026 Financial Model
-
CLEVELAND, April 06, 2026 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ABEO) today announced it has granted equity awards to new non-executive employees who joined the Company. The equity...
-
SAN JOSE, Calif., April 06, 2026 (GLOBE NEWSWIRE) -- Legence Corp. (Nasdaq: LGN) (“Legence” or the “Company”) today announced that selling stockholders affiliated with Blackstone Inc. (the “Selling...
-
NEW HAVEN, Conn., April 06, 2026 (GLOBE NEWSWIRE) -- Invivyd, Inc. (Nasdaq: IVVD) today announced that on April 1, 2026, Invivyd granted 16 newly hired non-executive employees options to purchase an...
-
SAN MATEO, Calif., April 06, 2026 (GLOBE NEWSWIRE) -- Sagimet Biosciences Inc. (Nasdaq: SGMT), a clinical-stage biopharmaceutical company developing novel therapeutics targeting dysfunctional...
-
Schindellegi, Switzerland – 6 April 2026 Trifork Group AGCompany announcement no. 23/2026 Weekly report on share buyback On 27 February 2026, Trifork initiated a share buyback program in...
-
WALTHAM, Mass., April 03, 2026 (GLOBE NEWSWIRE) -- Xilio Therapeutics, Inc. (Nasdaq: XLO), a clinical-stage biotechnology company discovering and developing masked immuno-oncology therapies for...